Lin, F. Y., Stuckert, A., Tat, C., White, M., Ruggieri, L., Zhang, H., Mehta, B., Lapteva, N., Mei, Z., Major, A., Thakkar, S., Shum, T., Parikh, K., Wu, M., Lindsay, H. B., Scherer, L., Shekar, M., Kinnear, D., Blessing, M. M., Baxter, P., Wang, T., Grilley, B., Moeller, K., Hicks, J., Roy, A., Anastas, J., Malbari, F., Aldave, G., Chintagumpala, M., Blaney, S., Parsons, D. W., Brenner, M. K., Heslop, H. E., Rooney, C. M., Omer, B. (2026). Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-00699